The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
P16INK4a expression after chemotherapy in older women with early-stage breast cancer.
H. B. Muss
No relevant relationships to disclose
J. Krishnamurthy
No relevant relationships to disclose
S. M. Alston
No relevant relationships to disclose
A. C. Lacy
No relevant relationships to disclose
T. A. Jolly
No relevant relationships to disclose
G. Williams
No relevant relationships to disclose
L. A. Carey
No relevant relationships to disclose
E. C. Dees
No relevant relationships to disclose
C. K. Anders
No relevant relationships to disclose
W. J. Irvin
No relevant relationships to disclose
N. E. Sharpless
Employment or Leadership Position - G-Zero Therapeutics (U)
Stock Ownership - G-Zero Therapeutics